
Home > Newsroom > 2008 > Appointment of New CEO of Takeda Pharmaceuticals Europe Limited
Main contents starts here
September 2, 2008
Osaka, Japan, September 2, 2008 --- Takeda Pharmaceutical Company Limited (“Takeda”) today announced the appointment of Dr. Erich Brunn as CEO of Takeda Pharmaceuticals Europe Limited (“TPEU”), its wholly owned subsidiary for oversight of pan-European sales & marketing.
Dr. Brunn has a doctorate in chemistry and, since 2001, has been President of Takeda Pharma GmbH, a wholly owned subsidiary of Takeda in Germany, having also previously worked at Upjohn GmbH, Pharmacia & Upjohn GmbH and Pharmacia GmbH in various functions.
“Dr. Brunn has a proven track record of success and excellence, which is apparent through the remarkable growth achieved by Takeda Pharma GmbH under his leadership,” said Yasuchika Hasegawa, President of Takeda. “We are confident that he will provide TPEU with the same level of success as he takes on this pivotal role as CEO of TPEU.”
“I am pleased to accept this exciting challenge to lead TPEU, which is a core organization for Takeda’s operations in Europe,” said Erich Brunn. “Through this role, I am determined to further enhance Takeda’s business foundation in Europe.”
TPEU supports and leads the overall business activities of Takeda’s six marketing subsidiaries in Europe[*] by promoting pan-European sales and marketing strategies. By maximizing the benefits of TPEU centered strategies in Europe, Takeda anticipates further growth of its business in the region.
[*] Laboratoires Takeda (France), Takeda UK Limited (UK), Takeda Italia Farmaceutici S.p.A. (Italy), Takeda Pharma GmbH (Germany), Takeda Pharma Ges.m.b.H (Austria), Takeda Pharma AG (Switzerland)
| Company name: | Takeda Pharmaceuticals Europe Limited |
| Location: | London, United Kingdom |
| Capital: | 4 million Sterling Pounds |
| Establishment: | August 2006 |
Located in Osaka, Japan, Takeda is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to striving toward better health for individuals and progress in medicine by developing superior pharmaceutical products. Additional information about Takeda is available through its corporate website, www.takeda.com.
# # #